Sientra reported 12.74M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 224.52M 6.13M
Align Technology ALGN:US $ 687.56M 21.79M
Cooper Companies COO:US $ 552.1M 19.6M
Dexcom DXCM:US $ 449.5M 51.4M
Globus Medical GMED:US $ 195.18M 23.8M
Insulet PODD:US $ 190.3M 19.4M
Integra Lifesciences IART:US $ 254.54M 15.94M
Johnson & Johnson JNJ:US $ 16101M 273M
Nuvasive NUVA:US $ 224.69M 13.03M
Sientra SIEN:US 12.74M 103K
Stryker SYK:US $ 2843M 116M
Teleflex TFX:US $ 388.83M 42.6M
Zimmer Biomet Holdings Inc ZBH:US $ 1.27B 107.6M